Why AMJ Is Unlikely to Go Nuclear

JPMorgan has capped the issuance of AMJ, but this doesn't mean the ETN will suffer the same type of collapse as TVIX and GAZ. More 

ETN Market Brewing for Implosion

The $16 billion ETN market is almost double in size from two years ago, despite the mounting global financial risk. Have ETN shareholders lost their minds? More 

JPMorgan Chase to Limit Number of AMJ Shares

With an estimated $70 trillion in global OTC derivatives exposure, JPMorgan is cutting back its swap exposure by capping the shares in its ETN program More 

The Troubling Evolution of Exchange-Traded ‘Products’

The exchange-traded products category has morphed in ways that can be extremely risky -- and worse, they can mislead uninformed investors into very unwise purchases. More 

ETN Sponsors’ ‘Double Dip’ Hurts Shareholders

Credit Suisse and Barclays have been double-dipping by lending out ETN shares to traders that short them, while simultaneously collecting fees from investors. More 

Volatility ETN Rears Its Ugly Head

The TVIX's recent rapid descent provides a valuable lesson about the dangers of ETNs and other volatility-tracking products. More 

Volatility Oddities Could Impact Broad Market

Interest in volatility products continues to grow despite low levels in the VIX. More